期刊文献+

血管紧张素Ⅱ参与肾小管上皮细胞转分化的实验研究 被引量:1

Experimental study of angiotensin Ⅱ(AngⅡ ) involved in renal epithelial-mesenchymal transition
下载PDF
导出
摘要 目的:本文通过观察血管紧张素Ⅱ(angiotensinⅡ,AngⅡ)影响肾小管上皮细胞转分化(epithelial-mesenchymal transition,EMT)的作用,以及和转化生长因子-β1(transforming growth factor,TGF-β1)作用的关系,探讨AngⅡ参与肾小管间质纤维化的作用机制。方法:以人肾小管上皮细胞株(human kidney cell)HKC细胞为研究对象,采用蛋白印迹等方法,观察AngⅡ(10-9、10-8、10-7、10-6mol/L),及其与TGF-β1共同作用对该细胞表达α-平滑肌肌动蛋白(α-smooth muscle actin,α-SMA)、E-钙黏蛋白(E-cadherin)和纤维连接蛋白(fibronectin,FN)的影响。明胶酶谱法检测细胞培养上清液中基质金属蛋白酶-2和基质金属蛋白酶-9(MMP-2和MMP-9)的变化,Boyden小室检测HKC细胞的迁移能力。结果:①单独应用AngⅡ不能够造成HKC细胞E-cadherin表达的变化,也不能诱导α-SMA表达,但是却能上调FN的表达;②与TGF-β1共同作用时能够加强TGF-β1影响E-cadherin,α-SMA和FN表达的作用;③AngⅡ能够增加HKC生成MMP-2和MMP-9;④AngⅡ能够(10-7和10-6mol/L)增加HKC细胞迁移至Boyden小室膜下侧面的数目。结论:①AngⅡ可以参与EMT过程,但不是导致EMT的关键因素;②AngⅡ能够以协同的方式参与TGF-β1导致的EMT,可能以此方式加重肾小管间质的纤维化。 Objective:To investigate the effect of Angiotensin Ⅱ (Ang Ⅱ )on renal tubular Epithelial-Mesenchymal transition,evaluate the relationship between Ang Ⅱ and transforming growth factor-β1 (TGF-β1) and discuss the mechanism of Ang Ⅱ involved in tubulointerstitial fibrosis. Methods:Human proximal tubular epithelial HKC cells were taken as research objects. They was maintained in DMEM/F12 medium supplemented with 10% newborn calf serum, α-SMA,E-cadherin and FN triggered by Ang Ⅱ (10^-9, 10^-8, 10^-7,10^-6 mol/L),and the combination of TGF-β1 were tested by Western blot. The changes of MMP-2 and MMP-9 in supernatant were detected by gelatin zymogramphy. The migration of HKC was assayed by Boyden chamber. Results: (1)In HKC induced by Ang Ⅱ only, the expression of α-SMA and E-cadherin proteins has no change, while FN was highly expressed. (2)α-SMA, E-cadherin and FN triggered by combination of TGF-β1 and Ang Ⅱ was up-regulated,and Ang Ⅱ could enhance the effect of TGF-β1. (3)Ang Ⅱ up-regulated MMP-2 and MMP-9 expressions of HKC. (4)Ang Ⅱ ( 10^-7, 10^-6 mol/L) could increase the number of cells that migrated across the filter and attached to the underside of boyden chamber. Conclusion: (1)Ang Ⅱ was involved in EMT,while it was not the critical factor of EMT. (2)Ang Ⅱ cooperated with TGF-β1 was involved in EMT and might aggravate tubulointerstitial fibrosis.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第5期623-627,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金资助(30470800,30771010) 科技部“973”重点项目(2006CB503909) 国家人事部回国人员科研启动基金 江苏省“六大人才”高峰项目 江苏省“科教兴卫”工程医学领军人才项目
关键词 血管紧张素Ⅱ 转化生长因子-Β1 转分化 纤维化 angiotensin Ⅱ TGF-β1 EMT fibrosis
  • 相关文献

参考文献14

  • 1Rastaldi MP. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis[J]. J Nephrol,2006, 19(4):407-412.
  • 2Matsusaka T, Katori H, Miyazaki Y,et al. An giotensin Ⅱ as a player in fibrosis [J]. Nephrol Dial Transplant, 2000, 15(Suppl 6):64-65.
  • 3Ruiz-Ortega M, Ruperez M, Esteban V, et al. Angiotensin Ⅱ :a key factor in the inflammatory and fibrotic response in kidney diseases [J]. Nephrol Dial Transplant,2006,21 (1):16-20.
  • 4Song JH, Cha SH, Kim DH,et al. Dual blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin Ⅱ receptor blockers in chronic kidney disease [J]. J Hypertens Suppl,2006,24 (1) :S101-106.
  • 5Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention [J]. J Am Soc Nephrol, 2004,15(1) : 1-12.
  • 6Yang J,Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis [J]. J Am Soc Nephrol,2002,13 (1) :96-107.
  • 7Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis [J]. Am J Pathol,2001,159 (4) : 1465-1475.
  • 8Wynn TA. Cellular and molecular mechanisms of fibrosis [J]. J Pathol,2008,214(2) : 199-210.
  • 9Neilson EG. Mechanisms of disease:Fibroblasts--a new look at an old problem [J]. Nat Clin Pract Nephrol, 2006,2(2) : 101-108.
  • 10Roberts AB,Tian F,Flanders KC,et al. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis,tumor suppression and metastasis [J]. Cytokine Growth Factor Rev,2006,17(1-2) : 19-27.

同被引文献11

  • 1Razzaque M S, Taguchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis[J].Med Electron Microse, 2002,35 : 68-80.
  • 2Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis[J]. Am J Pathol, 2001,159 : 1465-1475.
  • 3Yang J,Dai C, Liu Y. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction[J]. Am J Pathol, 2003,163 : 621-632.
  • 4Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis[J]. J Am Soc Nephrol, 2002,13 : 96-107.
  • 5Kalluri R, Neilson E G. Epithelial mesenchymal transition and its implications for fibrosis[J]. J Clin Invest, 2003,112 : 1776-1784.
  • 6Neilson E G. Mechanisms of disease: fibroblasts--a new look at an old problem[J]. Nat Clin Pract Nephrol, 2006,2:101-108.
  • 7Yamaguchi I, Lopez-Guisa J M, Cai X, Collins S J, Okamura D M, Eddy A A. Endogenous urokinase lacks antifibrotie activity during progressive renal injury[J]. Am J Physiol Renal Physiol,2007,293:F12-F19.
  • 8Kellner D, Chen J, Richardson I, Seshan S V, El Chaar M, Vaughan E D Jr,et al. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction[J].J Urol, 2006,176 : 806-812.
  • 9王海燕.重视和研究小管-间质损害在肾小球疾病发展和预后中的作用[J].中华肾脏病杂志,2000,16(1):5-6. 被引量:85
  • 10李恒,唐政.肾脏固有细胞病理变化与慢性肾功能减退[J].肾脏病与透析肾移植杂志,2000,9(6):543-546. 被引量:9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部